Clinical Trials
15 trialsNCT06844669 2026-05-13
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Terminated
NCT04044872 2026-02-02
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT03862131 2025-07-29
PROACT
Washington University School of Medicine
Phase 2 Terminated
NCT05029154 2025-06-12
Exercise Preconditioning in Ovarian Cancer
University of Virginia
Phase NA Terminated
NCT05781672 2025-02-19
SpeckleAnthra2
University Hospital, Montpellier
Phase NA Terminated
NCT05699915 2025-01-30
CAVACI
Algemeen Ziekenhuis Maria Middelares
Phase NA Terminated
NCT03850171 2023-02-27
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study
Insel Gruppe AG, University Hospital Bern
Phase NA Terminated
NCT02472353 2019-10-16
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
Avera McKennan Hospital & University Health Center
Phase 2 Terminated
NCT02674204 2019-05-15
STOP
Cedars-Sinai Medical Center
Phase 2 Terminated
NCT00728429 2017-05-30
Aerobic Exercise in Patients Receiving Chemotherapy for Cancer
Wake Forest University Health Sciences
Phase NA Terminated
NCT01120171 2015-10-07
Myocet Plus Endoxan for Older Patients With Breast Cancer
Hellenic Oncology Research Group
Phase 2 Terminated
NCT00377780 2015-09-23
MYOHERTAX
Catharina Ziekenhuis Eindhoven
Phase 2 Terminated
NCT00019864 2015-06-08
Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
National Cancer Institute (NCI)
Phase 2 Terminated
NCT01301040 2013-08-30
Early Cardiac Toxicity of Adjuvant CT in Elderly BC.
Jules Bordet Institute
Phase 2 Terminated
NCT00016276 2013-01-16
Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 3 Terminated